Prot #APTO-CG-806-03: A Phase 1a/b Trial of CG-806 in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Project: Research project

Project Details

StatusActive
Effective start/end date1/27/211/27/27

Funding

  • Aptose Biosciences Inc. ((OE) Prot #APTO-CG-806-03)